SRPT — Sarepta Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual balance sheet for Sarepta Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,125	1,939	2,116	1,989	1,676
Net Total Accounts Receivable
Net Total Receivables	93.9	139	172	260	440
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,469	2,485	2,604	2,558	2,579
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	168	282	237	245	357
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,823	2,985	3,148	3,128	3,265
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	265	416	453	620	654
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1,005	2,223	2,220	2,743	2,405
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	818	762	928	385	859
Total Liabilities & Shareholders' Equity	1,823	2,985	3,148	3,128	3,265
Total Common Shares Outstanding